{"schema_version":"secwatch.filing_event.v1","accession":"0001133421-22-000003","form_type":"8-K","ticker":"NOC","cik":"0001133421","company_name":"NORTHROP GRUMMAN CORP /DE/","filed_at":"2022-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.502724+00:00","generated_at":"2026-06-27T14:45:16.197414+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Northrop Grumman Q4 EPS $17.14 ($6.00 adjusted); FY21 sales $35.7B, adj. EPS $25.63 (+8% YoY)","bullets":["Q4 sales $8.6B; FY21 sales $35.7B, organic sales +3% YoY.","Q4 GAAP EPS $17.14 includes $11.14 MTM benefit; transaction-adjusted EPS $6.00.","FY21 transaction-adjusted EPS $25.63 (+8% YoY); cash from ops $3.6B, adj. free cash flow $3.1B.","Backlog $76.0B; board authorized additional $2.0B share repurchases.","2022 guidance: organic sales growth 2-3%; F-35 program recorded $73M COVID-related charge in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001133421-22-000003","json":"https://secwatch.observer/filing/0001133421-22-000003.json","markdown":"https://secwatch.observer/filing/0001133421-22-000003.md","text":"https://secwatch.observer/filing/0001133421-22-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133421/000113342122000003/0001133421-22-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133421/000113342122000003/noc-20220127.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:45:16.197414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}